- Report
- February 2025
- 240 Pages
Global
From €2579EUR$2,690USD£2,155GBP
- Report
- February 2025
- 90 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- April 2025
- 184 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- April 2025
- 93 Pages
Global
From €5369EUR$5,600USD£4,486GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- January 2025
- 135 Pages
Global
From €2875EUR$2,999USD£2,402GBP
- Report
- May 2024
- 140 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- May 2024
- 137 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- May 2024
- 133 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- October 2024
- 212 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- August 2024
- 233 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- October 2024
- 250 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- January 2025
- 182 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- September 2021
- 40 Pages
China
From €2493EUR$2,600USD£2,083GBP
- Report
- November 2023
- 139 Pages
Global
From €4266EUR$4,450USD£3,565GBP
- Report
- August 2022
- 115 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2024
- 395 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- August 2022
- 111 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 29 Pages
Global
€16441EUR$17,150USD£13,737GBP

Levetiracetam is a medication used to treat epilepsy and other seizure disorders. It is a type of anticonvulsant drug, which works by reducing the abnormal electrical activity in the brain that causes seizures. Levetiracetam is used to treat partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It is also used to treat Lennox-Gastaut syndrome, a rare form of epilepsy. Levetiracetam is part of the Central Nervous System (CNS) drug market, which includes medications used to treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. The CNS drug market is highly competitive, with many different drugs available to treat the same condition.
Companies in the Levetiracetam market include UCB, Inc., Sun Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., and Teva Pharmaceutical Industries Ltd. Show Less Read more